XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details) - USD ($)
$ in Millions
 3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net $ (1) $ 2
Exit and other-related costs 8 22
Asset impairments and accelerated depreciation 3 28
Total 10 52
Operating Segments | U.S. Pharmaceutical    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 1
Exit and other-related costs 0 1
Asset impairments and accelerated depreciation 1 0
Total 1 2
Operating Segments | Prescription Technology Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 3 2
Asset impairments and accelerated depreciation 1 0
Total 4 2
Operating Segments | Medical-Surgical Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 3 2
Asset impairments and accelerated depreciation 0 0
Total 3 2
Operating Segments | International    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 0 5
Asset impairments and accelerated depreciation 1 1
Total 1 6
Corporate    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net (1) 1
Exit and other-related costs 2 12
Asset impairments and accelerated depreciation 0 27
Total $ 1 $ 40